AMDCP Credit Designation: This session has been approved for a total of 1.5 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
The American Medical Directors Association designates this educational activity fora maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Presenter(s): Catherine M. Eberle, MD, CMD(Moderator); Jay Luxenberg, MD; David A. Nace, MD, MPH; Ladislav Volicer, MD,PhD; Deborah Gavin-Dreschnack, PhD; Cheryl Morris, RN, MS; Rollin M. Wright,MD, MA, MPH Disclosure(s): All presenters reported they had no relevant financial relationships to disclose. Session Description: This session delivers a variety of pearls straight from the nursing facility setting. The first pearl delves into innovations in the use of ambient lighting and light therapy to address problems associated with dementia and frailty in long term care residents. The second pearl focuses on the concrete problem of in appropriate use of wheelchairs and how alternatives could be implemented to improve the quality of life. Lastly, in this session the issue of influenza immunization rates among healthcare workers in long term care settings will be addressed, using the current efforts of the University of Pittsburgh Institute on Aging’s work as an example of how to apply strategies the audience’s respective settings. Learning Objectives:
Discuss how newly recognized photoreceptors in the retina, calledcryptochrome receptors, has altered our therapies to address circadianrhythm abnormalities
Identify the risks associated with particular portions of the visiblelight spectrum
Describe the problems of wheelchairs in the long term care setting and possible solutions to be implemented
Implement a program for increasing the rates of influenzaimmunization among healthcare workers
References: Dowling, GA, RL Burr, EJ Van Someren, EM Hubbard, JSLuxenberg, J Mastick, and BA Cooper. Melatonin and Bright-Light Treatment forRest-Activity Disruption in Institutionalized Patients With Alzheimer'sDisease. J Am Geriatr Soc; 56: 239-246 2008 Dowling, GA, CL Graf, EM Hubbard, andJS Luxenberg. Light Treatment for Neuropsychiatric Behaviors in Alzheimer’sDisease. West J Nurs Res 29: 961-975. 2007 Dowling GA, Hubbard EM, Mastick J,Luxenberg JS, Burr RL, Van Someren EJ. Effect of morning bright light treatmentfor rest-activity disruption in institutionalized patients with severeAlzheimer's disease. Int Psychogeriatr. Jun;17(2):221-36. 2005 Dowling GA, Mastick J, Hubbard EM,Luxenberg JS, Burr RL. Effect of timed bright light treatment for rest-activitydisruption in institutionalized patients with Alzheimer's disease. Int JGeriatr Psychiatry. Aug;20(8):738-43. 2005